TREM2 and Parkinson disease: DDRs levels are increased in postmortem PD brains and Nilotinib enhances neurotoxic protein clearance, attenuates cell death and reduces the number of TREM2 + microglia,47 suggesting regulation of myeloid‐derived microglia and protection against neurotoxic proteins.